ATE341338T1 - Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung - Google Patents

Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung

Info

Publication number
ATE341338T1
ATE341338T1 AT00919412T AT00919412T ATE341338T1 AT E341338 T1 ATE341338 T1 AT E341338T1 AT 00919412 T AT00919412 T AT 00919412T AT 00919412 T AT00919412 T AT 00919412T AT E341338 T1 ATE341338 T1 AT E341338T1
Authority
AT
Austria
Prior art keywords
production
tumor cells
modified tumor
hapten modified
hapten
Prior art date
Application number
AT00919412T
Other languages
English (en)
Inventor
David Berd
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE341338T1 publication Critical patent/ATE341338T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00919412T 1999-03-16 2000-03-15 Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung ATE341338T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12467299P 1999-03-16 1999-03-16

Publications (1)

Publication Number Publication Date
ATE341338T1 true ATE341338T1 (de) 2006-10-15

Family

ID=22416199

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919412T ATE341338T1 (de) 1999-03-16 2000-03-15 Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung

Country Status (9)

Country Link
US (1) US6403104B1 (de)
EP (2) EP1723963A3 (de)
AR (1) AR022937A1 (de)
AT (1) ATE341338T1 (de)
AU (1) AU757980B2 (de)
CA (1) CA2367922A1 (de)
DE (1) DE60031100T2 (de)
ES (1) ES2273680T3 (de)
WO (1) WO2000057911A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057911A2 (en) * 1999-03-16 2000-10-05 Thomas Jefferson University Hapten-conjugated mammalian cells and methods of making and using thereof
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
EP1480660A4 (de) * 2002-02-01 2008-02-20 Univ Jefferson Gemischte haptenisierte tumorzellen und extrakte und verfahren zur krebsbehandlung oder -untersuchung
WO2003103389A2 (en) * 2002-06-10 2003-12-18 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
US7674456B2 (en) * 2004-06-14 2010-03-09 Charles Wiseman Breast cancer cell lines and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
AU2006204896A1 (en) * 2005-01-14 2006-07-20 Avax Technologies, Inc. Method for producing a vaccine for the treatment of cancer
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
CN105358176A (zh) * 2013-02-01 2016-02-24 衣阿华大学研究基金会 肿瘤疫苗及其使用方法
WO2018187259A1 (en) * 2017-04-05 2018-10-11 University Of Miami Methods and compositions for stimulating the immune system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290557A (en) 1992-07-16 1994-03-01 W. Neudorff Gmbh Kg Saponin containing anti-feedant and molluscicide for terrestrial mollusc control
ES2302337T3 (es) * 1995-06-07 2008-07-01 Thomas Jefferson University Extracto de celulas tumorales modificadas con hapteno y procedimientos para tratar cancer.
PL328790A1 (en) 1996-10-04 1999-02-15 Univ Jefferson T-lymphocytes provoking an immunological response and methods of using them
AR020067A1 (es) 1998-04-09 2002-04-10 Univ Jefferson Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma
WO2000057911A2 (en) * 1999-03-16 2000-10-05 Thomas Jefferson University Hapten-conjugated mammalian cells and methods of making and using thereof

Also Published As

Publication number Publication date
WO2000057911A3 (en) 2001-01-18
DE60031100T2 (de) 2007-03-08
ES2273680T3 (es) 2007-05-16
US6403104B1 (en) 2002-06-11
DE60031100D1 (de) 2006-11-16
WO2000057911A2 (en) 2000-10-05
EP1723963A2 (de) 2006-11-22
EP1162996B1 (de) 2006-10-04
EP1723963A3 (de) 2008-05-07
CA2367922A1 (en) 2000-10-05
AR022937A1 (es) 2002-09-04
AU4010600A (en) 2000-10-16
AU757980B2 (en) 2003-03-13
EP1162996A2 (de) 2001-12-19

Similar Documents

Publication Publication Date Title
DE69934890D1 (de) Glykosulfopeptide und verfahren zu deren herstellung und deren verwendung
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
DE69936050D1 (de) Graben-gate halbleiterbauelemente und verfahren zur deren herstellung
DE60002505D1 (de) Lithium kobaltoxide und verfahren zur herstellung
DE69932361D1 (de) Trennschicht und verfahren zu deren herstellung
DE69820119D1 (de) Gelierte nahrungsmittel sowie verfahren zu deren herstellung
DE69927681D1 (de) Fluoreszierende körnchen, verfahren zur herstellung und verwendung in fälschungssicheren papieren
DE69816758D1 (de) Synthetisches quarzglas zur verwendung in uv-strahlung und verfahren zu seiner herstellung
DE69941054D1 (de) Isosorbid enthaltende poyester und verfahren zu deren herstellung
DE69804825D1 (de) Zellulosebahn mit verschiedenen dichtebereichen und verfahren zu seiner herstellung
DE69921099D1 (de) Wärmeausdehnbare mikrokapseln, verfahren zur herstellung und verwendung derselben
DE60033156D1 (de) Glasscheibe und verfahren zu dessen herstellung
DE69819015D1 (de) Norbonenpolymer und verfahren zur herstellung
DE69928785D1 (de) Ligationsband mit abgerundeten kanten und verfahren zur dessen herstellung
DE60018805D1 (de) Oberflächenmodifiziertes anorganisches oxidpulver, verfahren zur herstellung desselben und verwendung desselben
DE60045480D1 (de) Druckempfindliches klebeband und verfahren zur herstellung desselben
DE69901178D1 (de) Nichtgesinterte elektrode und verfahren zur herstellung
DE69725329D1 (de) Richtungsweisende markierung mit hervortretenden erhebungen und verfahren zur herstellung
ATE288577T1 (de) Ladeluftkühler und verfahren zu dessen herstellung
DE69815126D1 (de) Pyrimidinderivate und verfahren zu deren herstellung
DE60037186D1 (de) Einfaches kulturmedium und verfahren zu dessen herstellung
ATE341338T1 (de) Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung
DE60032943D1 (de) Imid-benzoxazolpolykondensat sowie verfahren zur herstellung
ATE234842T1 (de) Epithilonderivate, verfahren zu deren herstellung und deren verwendung
DE69812365D1 (de) Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties